INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,300 | -22.5% | 15,000 | 0.0% | 0.01% | -30.8% |
| Q2 2023 | $611,700 | +9.4% | 15,000 | 0.0% | 0.01% | +18.2% |
| Q1 2023 | $559,050 | +60.2% | 15,000 | +50.0% | 0.01% | +83.3% |
| Q4 2022 | $348,900 | -37.7% | 10,000 | 0.0% | 0.01% | -45.5% |
| Q3 2022 | $560,000 | +8.1% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $518,000 | -28.7% | 10,000 | 0.0% | 0.01% | -26.7% |
| Q1 2022 | $727,000 | -38.5% | 10,000 | 0.0% | 0.02% | -42.3% |
| Q4 2021 | $1,182,000 | -11.9% | 10,000 | 0.0% | 0.03% | -16.1% |
| Q3 2021 | $1,342,000 | -17.1% | 10,000 | 0.0% | 0.03% | -6.1% |
| Q2 2021 | $1,619,000 | +101.6% | 10,000 | 0.0% | 0.03% | +83.3% |
| Q1 2021 | $803,000 | +47.6% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $544,000 | +173.4% | 10,000 | 0.0% | 0.02% | +125.0% |
| Q3 2020 | $199,000 | -5.2% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $210,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |